Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2431-2439

  Niki, Toshiro ^a   Iba, Sanae ^a   Tokunou, Masahide ^a   Yamada, Tesshi ^a   Matsuno, Yoshihiro ^a   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 0034093853     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Senger, D. R., Van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
2. Korpelainen, E. I., and Alitalo, K. Signaling angiogenesis and lymphangiogenesis. Curr. Opin. Cell Biol., 10: 159-164, 1998.
3. Beck, L. J., and D'Amore, P. Vascular development: cellular and molecular regulation. FASEB J., 11: 365-373, 1997.
4. Ellis, L., and Fidler, I. Angiogenesis and metastasis. Eur. J. Cancer, 32A: 2451-2460, 1996.
5. Nicosia, R. F. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am. J. Pathol., 153: 11-16, 1998.
6. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15: 290-298, 1996.
7. Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., and Wood, W. I. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA, 93: 1988-1992, 1996.
8. Hu, J. S., Hastings, G. A., Cherry, S., Gentz, R., Ruben, S., and Coleman, T. A. A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells. FASEB J., 11: 498-504, 1997.
9. Fitz, L. J., Morris, J. C., Towler, P., Long, A., Burgess, P., Greco, R., Wang, J., Gassaway, R., Nickbarg, E., Kovacic, S., Ciarletta, A., Giannotti, J., Finnerty, H., Zollner, R., Beier, D. R., Leak, L. V., Turner, K. J., and Wood, C. R. Characterization of murine Flt4 ligand/VEGF-C. Oncogene, 15: 613-618, 1997.
10. Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V., Fang, G., Dumont, D., Breitman, M., and Alitalo, K. Expression of the fms-like tyrosine kinase 4 becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA, 92: 3566-3570, 1995.
11. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., and Alitalo, K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development (Camb.), 122: 3829-3837, 1996.
12. Oh, S. J., Jeltsch, M. M., Birkenhager, R., McCarthy, J. E., Weich, H. A., Christ, B., Alitalo, K., and Wilting, J. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol., 188: 96-109, 1997.
13. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., and Alitalo, K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (Washington DC), 276; 1423-1425, 1997.
14. Tsurusaki, T., Kanda, S., Sakai, H., Kanetake, H., Saito, Y., Alitalo, K., and Koji, T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br. J. Cancer, 80: 309-313, 1999.
15. Yonemura, Y., Endo, Y., Fujita, H., Fushida, S., Ninomiya, I., Bandou, E., Taniguchi, K., Miwa, K., Ohoyama, S., Sugiyama, K., and Sasaki, T. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res., 5: 1823-1829, 1999.
16. Orlandini, M., Marconcini, L., Ferruzzi, R., and Oliviero, S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc. Natl. Acad. Sci. USA, 93: 11675-11680, 1996.
17. Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., Alitalo, K., and Stacker, S. A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA, 95: 548-553, 1998.
18. Yamada, Y., Nezu, J., Shimane, M., and Hirata, Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics, 42: 483-488, 1997.
19. Naruke, T., Goya, T., and Tsuchiya, R. Prognosis and survival in resected lung carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg., 96: 440-447, 1988.
20. Miller, J. D., Gorenstein, L. A., and Patterson, G. A. Staging. The key to rational management of lung cancer. Ann. Thorac. Surg., 53: 170-178, 1992.
21. Ohta, Y., Watanabe, Y., Murakami, S., Oda, M., Hayashi, Y., Nonomura, A., Endo, Y., and Sasaki, T. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br. J. Cancer, 76: 1041-1045, 1997.
22. Fontanini, G., Boldrini, L., Chine, S., Pisaturo, F., Basolo, F., Calcinai, A., Lucchi, M., Mussi, A., Angeletti, C. A., and Bevilacqua, G. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. Br. J. Cancer, 79: 363-369, 1999.
23. Ishigami, S. I., Arii, S., Furutani, M., Niwano, M., Harada, T., Mizumoto, M., Mori, A., Onodera, H., and Imamura, H. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br. J. Cancer, 78: 1379-1384, 1998.
24. Salven, P., Lymboussaki, A., Heikkila, P., Jaaskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K., and Joensuu, H. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am. J. Pathol., 153: 103-108, 1998.
25. Sowter, H. M., Corps, A. N., Evans, A. L., Clark, D. E., and Charnock-Jones, D. S., and Smith, S. K. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab. Investig., 77: 607-614, 1997.
26. Noguchi, M., Morikawa, A., Kawasaki, M., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., and Shimosato, Y. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer (Phila.), 75: 2844-2852, 1995.
27. Sobin, L., and Wittekind, L. H. TNM classification of malignant tumours. New York: John Wiley & Sons, Ltd., 1997.
28. Gibson, U. E., Heid, C. A., and Williams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996.
29. Livak, K., Flood, S., Marmaro, J., Giusti, W., and Deetz, K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl., 4: 357-362, 1995.
30. Bieche, I., Laurendeau, I., Tozlu, S., Olivi, M., Vidaud, D., Lidereau, R., and Vidaud, M. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res., 59: 2759-2765, 1999.
31. Bieche, I., Olivi, M., Champeme, M. H., Vidaud, D., Lidereau, R., and Vidaud, M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int. J. Cancer, 78: 661-666, 1998.
32. Kornmann, M., Danenberg, K., Arber, N., Beger, H., Danenberg, P., and Kore, M. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res., 59: 3505-3511, 1999.
33. Joukov, V., Kumar, V., Sorsa, T., Arighi, E., Weich, H., Saksela, O., and Alitalo, K. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J. Biol. Chem., 273: 6599-6602, 1998.
34. Toi, M., Taniguchi, T., Yamamato, Y., Kurisaki, T., Suzuki, H., and Tominaga, T. Clinical significance of the determination of angiogenic factors. Eur. J. Cancer, 32A: 2513-2519, 1996.